This study investigates advanced solid tumors with specific mutations in RAS. The purpose of this study is to evaluate a treatment for these types of tumors.
The study focuses on evaluating the safety, tolerability, and effectiveness of the treatment in participants. It looks at how the treatment works and its impact on the tumors.
- Who can participate: Adults aged 18 and older with solid tumors that have specific RAS mutations can participate. They must have tried standard treatments and have a good performance status.
- Study details: Participants will take an investigational medication that targets RAS mutations.